SCHEMBL26547901

SCHEMBL26547901

CC(C)Nc1cc(-c2ccncc2)[nH]n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 5/20 0.46
ROCK1 Q13464 5/20 0.46
APP P05067 3/20 0.41
TNIK Q9UKE5 2/20 0.41
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NR1I2 O75469 1/20 0.40
AHR P35869 1/20 0.40
PDPK1 O15530 1/20 0.39
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25431149 0.85 RAB9A (0.53) TNIKRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL26547900 0.81 CHEK1 (0.55) TNIKPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL22761274 0.77 SMN1; SMN2 (0.44) ROCK2ROCK1APPTNIKRAB9A
SCHEMBL26551637 0.77 APP (0.51) ROCK2ROCK1APPTNIKRAB9A
SCHEMBL2769883 0.74 RAB9A (0.71) ROCK2ROCK1TNIKRAB9ANPC1
SCHEMBL6235520 0.74 PDPK1 (0.42) ROCK2ROCK1RAB9ANPC1SMN1; SMN2
SCHEMBL26552175 0.73 CYP1A2 (0.48) RAB9ANPC1SMN1; SMN2KDM4EALDH1A1
SCHEMBL3464281 0.71 PDPK1 (0.47) RAB9ANPC1SMN1; SMN2PDPK1ALDH1A1
SCHEMBL31672144 0.69 RAB9A (0.67) RAB9ANPC1PDPK1ALDH1A1MAPT
SCHEMBL14236038 0.69 TRPM8 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed